'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart

Circulation

Volumn 95, Issue 8, 1997, Pages 2122-2129

  Pepe, Salvatore ^a   Xiao, Rui Ping ^a   Hohl, Charlene ^b   Altschuld, Ruth ^b   Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

adrenergic, beta; cAMP; opioid peptides; proteins; rats; receptors

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE ENKEPHALIN; NALOXONE; NORADRENALIN; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; PERTUSSIS TOXIN; RECEPTOR SUBTYPE; ZINTEROL;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEART; HEART LEFT VENTRICLE PRESSURE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0030966402     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2122     Document Type: Article

References (55)

1. Holaday JW. Cardiovascular effects of the endogenous opiate system. Annu Rev Pharmacol Toxicol. 1983;23:541-594.
2. Caffrey JL, Boluyt MO, Younes A, Barron BA, O'Neill L, Crow MT, Lakatta EG. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the F344 rat. J Mol Cell Cardiol. 1994;26: 701-711.
3. Boluyt MO, Younes A, Caffrey JL, O'Neill L, Barron BA, Crow MT, Lakatta EG. Age-associated increase in rat cardiac opioid production. Am J Physiol. 1993;265:H212-H218.
4. Springhorn JP, Claycomb WC. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol. 1992;264:H1560-H1566.
5. Springhorn JP, Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J. 1989;258:73-78.
6. Howells RD, Kilpatrick DL, Bailey LC, Noe M, Udenfriend S. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci U S A. 1986;83:1960-1963.
7. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta. 1989;987:69-74.
8. 3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol. 1991;23:1297-1302.
9. 2+-transients and intracellular pH in cultured cardiac myocytes. J Mol Cell Cardiol. 1993;26:599-613.
10. 2+ channel current. J Mol Cell Cardiol. 1993;25:661-666.
11. 2+ release from an intracellular pool in myocytes and neurons. Circ Res. 1992;70:66-81.
12. 2+ in cardiac myocytes. Am J Physiol. 1991;261:H1671-H1674.
13. Clô C, Pignatti C, Tantini B, Ventura C, Bernardi P. Opioids regulate cyclic nucleotide levels in cultured heart cells (HC). J Mol Cell Cardiol. 1984;16(suppl 2):7. Abstract.
14. 1-13 on cardiac rhythm and cyclic adenosine monophosphate (cAMP) levels in the isolated perfused rat heart. Neurosci Lett. 1987;80:289-292.
15. Tsang D, Tan AT, Henry JL, Lal S. Effect of opioid peptides on L-noradrenaline-stimulated cAMP formation in homogenates of rat cerebral cortex and hypothalamus. Brain Res. 1978;152:521-527.
16. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994;269:19151-19156.
17. 2-adrenergic stimulation. Circulation. 1995;92:1612-1618.
18. 2+ transients. Circ Res. 1991;69:1369-1379.
19. 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic calcium, and calcium current in single rat ventricular cells. Circ Res. 1993;73:286-300.
20. Xiao R-P, Spurgeon HA, O'Connor F, Lakatta EG. Age-associated changes in β-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest. 1994;94:2051-2059.
21. 2+ current. Circulation. 1995;92(suppl I):I-432. Abstract.
22. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322-329.
23. England PJ, Shahid M. Effects of forskolin on contractile responses and protein phosphorylation in the isolated perfused rat heart. Biochem J. 1987;246:687-695.
24. Xiao R-P, Pepe S, Capogrossi MC, Spurgeon H, Lakatta EG. Opioid peptide receptor stimulation reverses β-adrenergic effects in rat heart cells. Am J Physiol. In press.
25. Buxton ILO, Brunton LL. Action of cardiac alpha 1-adrenergic receptors: activation of cyclic AMP degradation. J Biol Chem. 1985; 260:6733-6737.
26. Endoh M, Yamashita S. Differential response to carbachol, sodium nitroprusside and 8-bromo-guanosine-3′5′-monophosphate of atrial and ventricular muscle. Br J Pharmacol. 1981;73:393-399.
27. Gilman AG. G proteins: transducers of receptor generated signal. Annu Rev Biochem. 1987;56:615-649.
28. Law PY, Loh HH. δ-Opioid-receptor activates cAMP phosphodiesterase activities in neuroblastoma×glioma NG108-15 hybrid cells. Mol Pharmacol. 1993;43:684-693.
29. i2. Biochem J. 1990;267:391-398.
30. Prather PL, Loh HH, Law PY. Interaction of δ-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol. 1994;45:997-1003.
31. Laugwitz K-L, Offermanns S, Spicher K, Schultz G. μ and δ Opioid receptors differentially couple to G protein subtypes in human neuroblastoma SH-SY5Y cells. Neuron. 1993;10:233-242.
32. 2-Adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem. 1996;158:19-26.
33. Jin W, Lee NM, Loh HH, Thayer SA. Opioids mobilize calcium from inositol 1,4,5-triphosphate-sensitive stores in NG108-15 cells. J Neurosci. 1994;14:1920-1929.
34. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature. 1989;341:197-205.
35. 2+ in rat cardiac myocytes. Circ Res. 1990;66:1143-1155.
36. q. Science. 1991;251:804-807.
37. 2 by the α and βγ subunits of the trimeric GTP-binding protein. Proc Natl Acad Sci U S A. 1993;90:5297-5301.
38. Sharma SK, Klee WA, Nirenberg M. Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci U S A. 1977;74: 3365-3369.
39. s-stimulated adenylate cyclase. J Neurochem. 1988;50:543-553.
40. Linden J, Hollen CE, Patel A. The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium: correlation with cAMP and receptor densities. Circ Res. 1985;56: 728-735.
41. Brown LA, Humphrey SM, Harding SE. The anti-adrenergic effect of adenosine and its blockade by pertussis toxin: a comparative study in myocytes isolated from guinea-pig, rat and failing human hearts. Br J Pharmacol. 1990;101:484-488.
42. Bartel S, Karczewski P, Krause E-G. Protein phosphorylation and cardiac function: cholinergic-adrenergic interaction. Cardiovasc Res. 1993;27:1948-1953.
43. Hilal-Dandan R, Urasawa K, Brunton L. Endothelin inhibits adenylate cyclase and stimulates phosphoinositide hydrolysis in adult cardiac myocytes. J Biol Chem. 1992;267:10620-10624.
44. Hilal-Dandan R, Merck DT, Lujan JP, Brunton LL. Coupling of the endothelin type A receptor to multiple responses in adult rat cardiac myocytes. Mol Pharmacol. 1994;45:1183-1190.
45. Vogelsang M, Broede-Sitz A, Schäfer E, Zerkowski HR, Brodde OE. Endothelin A receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol. 1994;23:344-347.
46. 2+ independent in isolated adult feline cardiac myocytes. Life Sci. 1996;58:115-123.
47. Brown JH, Buxton ILO, Brunton LL. α-Adrenergic and muscarinic cholinergic stimulation of phosphoinositide hydrolysis in adult rat cardiomyocytes. Circ Res. 1985;57:532-537.
48. Kohl C, Linck B, Schmitz W, Scholz H, Scholz J, Toth M. Effects of carbachol and (-)-N6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction. Br J Pharmacol. 1990;101:829-834.
49. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-97.
50. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
51. Kita H, Miura T, Tsuchida A, Sakamoto J, Imura O. Roles of opioid receptor and protein kinase C in suppression of reperfusion arrhythmia by preconditioning. J Mol Cell Cardiol. 1995;27:A520. Abstract.
52. Miki T, Downey JM. Opioid receptors participate in ischemic preconditioning in rabbits. J Mol Cell Cardiol. 1996;28:A187. Abstract.
53. Oullette M, Brakier-Gingras L. Increase in the relative abundance of proenkephalin A mRNA in the ventricles of cardiomyopathic hamsters. Biochem Biophys Res Commun. 1988;155:449-454.
54. Dumont M, Oullette M, Brakier-Gingras L, Lemaire S. Circadian regulation of the biosynthesis of cardiac met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci. 1991;48:1895-1902.
55. Imai N, Kashiki M, Woolf PD, Liang C-S. Comparison of cardiovascular effects of μ- and δ-OPR antagonists in dogs with congestive heart failure. Am J Physiol. 1994;267:H912-H917.